Cigna (NYSE:CI) released its earnings results on Thursday. The health services provider reported $5.81 earnings per share for the quarter, topping analysts’ consensus estimates of $5.15 by $0.66, MarketWatch Earnings reports. Cigna had a return on equity of 15.89% and a net margin of 3.41%. The firm had revenue of $39.27 billion during the quarter, compared to the consensus estimate of $37.93 billion. During the same period in the prior year, the firm posted $4.30 earnings per share. The firm’s revenue for the quarter was up 14.2% compared to the same quarter last year. Cigna updated its FY 2020
Pre-Market guidance to 18.00-18.60 EPS and its FY20 guidance to $18.00-18.60 EPS.
NYSE CI opened at $172.69 on Friday. Cigna has a 1-year low of $118.50 and a 1-year high of $224.64. The company has a current ratio of 0.74, a quick ratio of 0.67 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $63.72 billion, a PE ratio of 12.29, a price-to-earnings-growth ratio of 0.85 and a beta of 0.70. The firm’s fifty day simple moving average is $184.19 and its 200-day simple moving average is $189.90.
In other Cigna news, CEO David Cordani sold 150,531 shares of the stock in a transaction on Friday, June 5th. The shares were sold at an average price of $208.40, for a total transaction of $31,370,660.40. Following the transaction, the chief executive officer now directly owns 145,873 shares of the company’s stock, valued at $30,399,933.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director John Partridge sold 2,700 shares of the stock in a transaction on Monday, July 13th. The stock was sold at an average price of $180.04, for a total transaction of $486,108.00. Following the transaction, the director now directly owns 27,216 shares in the company, valued at $4,899,968.64. The disclosure for this sale can be found here. Insiders sold 231,802 shares of company stock worth $48,470,825 over the last ninety days. 0.90% of the stock is currently owned by company insiders.
Cigna Company Profile
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
See Also: High-Yield Dividend Stocks
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.